Batista, Milene Tavares; Ferreira, Ewerton Lucena; Pereira, Gisela de Souza; Stafford, Phillip; Maeda, Denicar Lina Nascimento Fabris; Rodrigues, Juliana Falcão; Brady, L. Jeannine; Johnston, Stephen Albert; Ferreira, Luís Carlos de Souza 
; Ferreira, Rita de Cássia Café
Subjects: STREPTOCOCCUS MUTANS, ANTICORPOS MONOCLONAIS, ADJUVANTES IMUNOLÓGICOS, PEPTÍDEOS, CAMUNDONGOS, IMUNOGENICIDADE DA VACINA, EPITOPOS, VACINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BATISTA, Milene Tavares et al. LT adjuvant modulates epitope specificity and improves the efficacy of murine antibodies elicited by sublingual vaccination with the N-terminal domain of Streptococcus mutans P1. Vaccine, v. 35, n. 52, p. 7273-7282, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2017.11.007. Acesso em: 31 out. 2024.APA
Batista, M. T., Ferreira, E. L., Pereira, G. de S., Stafford, P., Maeda, D. L. N. F., Rodrigues, J. F., et al. (2017). LT adjuvant modulates epitope specificity and improves the efficacy of murine antibodies elicited by sublingual vaccination with the N-terminal domain of Streptococcus mutans P1. Vaccine, 35( 52), 7273-7282. doi:10.1016/j.vaccine.2017.11.007NLM
Batista MT, Ferreira EL, Pereira G de S, Stafford P, Maeda DLNF, Rodrigues JF, Brady LJ, Johnston SA, Ferreira LC de S, Ferreira R de CC. LT adjuvant modulates epitope specificity and improves the efficacy of murine antibodies elicited by sublingual vaccination with the N-terminal domain of Streptococcus mutans P1 [Internet]. Vaccine. 2017 ; 35( 52): 7273-7282.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.vaccine.2017.11.007Vancouver
Batista MT, Ferreira EL, Pereira G de S, Stafford P, Maeda DLNF, Rodrigues JF, Brady LJ, Johnston SA, Ferreira LC de S, Ferreira R de CC. LT adjuvant modulates epitope specificity and improves the efficacy of murine antibodies elicited by sublingual vaccination with the N-terminal domain of Streptococcus mutans P1 [Internet]. Vaccine. 2017 ; 35( 52): 7273-7282.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.vaccine.2017.11.007
